Beneficial clinical effects of cyclosporin A on severe psoriasis and its dissociation from serum concentration of soluble interleukin-2 receptor, soluble interleukin-6 receptor, soluble CD14 antigen, soluble intercellular adhesion molecule-1, and soluble vascular cell adhesion molecule-1

Archives of Dermatological Research

Volumn 289, Issue 1, 1996, Pages 57-59

  Yamamoto, Toshiyuki ^a   Kimura, Kyoko ^a   Katayama, Ichiro ^a   Koyano, Taeko ^b   Mamada, Akira ^c   Miyazaki, Kazuhiro ^d   Irimajiri, Toshikatsu ^e   Furuse, Yoshiro ^f   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Toride Kyodo General Hospital   (Japan)

^c TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^d Kameda General Hospital   (Japan)

^e Nakano General Hospital   (Japan)

^f Kiryu Kosei General Hospital   (Japan)

Author keywords

Cyclosporin; Cytokine; Psoriasis

Indexed keywords

CD14 ANTIGEN; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KERATINOCYTE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD14; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030450133     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050154     Document Type: Article

References (24)

1. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871-884
2. Valdimarsson H, Baker BS, Jonsdottir I, Fry L (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 7:256-259
3. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Bontin B, Yarchoan R, Nelson DL (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172-3177
4. Bazil V, Stominger JL (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567-1574
5. Lisby S, Ralfkiaer E, Rothlein R, Vejlsgaard GL (1989) Intercellular adhesion molecule-1 (ICAM-1) expression correlated to inflammation. Br J Dermatol 120:479-484
6. Vejlsgaard GL, Ralfkiaer E, Avnstorp C, et al. (1989) Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J Am Acad Dermatol 20:782-790
7. Kapp A, Piskorski A, Schopf E (1988) Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis. Br J Dermatol 119:707-710
8. Schopf RE, Dobmeyer J, Dobmeyer Th, Morsches B (1993) Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis. Dermatology 186:45-49
9. Schopf RE, Naumann S, Rehder M, Morsches B (1993) Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. Br J Dermatol 128:34-37
10. Ameglio F, Bonifati C, Pietravalle M, Fazio M (1994) Interleukin-6 and tumor necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology 189:359-363
11. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
12. Nickoloff BJ, Griffiths CEM (1990) Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation. J Invest Dermatol 95:35S-37S
13. Rice GE, Munro JM, Corless C, Bevilacqua MP (1991) Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 138:385-393
14. Cauducci M, Mussi A, Bonifati C, Fazio M, Ameglio F (1994) sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severity. Arch Dermatol Res 286:420-421
15. Ameglio F, Bonifati C, Carducci M, Alemanno L, Sacerdoti G, Fazio M (1994) Soluble intercellular adhesion molecule-1 and procollagen peptide are reliable markers of disease severity in psoriasis. Acta Derm Venereol (Stockh) 186 [Suppl]:19-20
16. Kowakzick L, Bildau H, Neuber K, Kohler I, Ring J (1993) Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Arch Dermatol Res 285:233-235
17. Kowalzick L, Weichenthal M (1994) Serum levels of sICAM-1, sELAM-1 and sIL-2R in patients with severe psoriasis: no relationship with disease activity. Arch Dermatol Res 286:422
18. Kammett D, Symons JA, Colver GB, Duff GW (1990) Serum soluble interleukin 2 receptor in psoriasis. Acta Derm Venerol (Stockh) 70:264-267
19. Duncan JI, Horrocks C, Ormerod AD, Powles AV, Whiting PH, Fry L, Thomson AW (1991) Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy. Clin Exp Immunol 85:293-296
20. Rie MA de, Hamerlinck F, Hintzen RQ, Bos JD, Lier RAW van (1991) Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin 2 receptor in serum patients with psoriasis. Arch Dermatol Res 283:533-534
21. Schopf RE, Hocher J, Schutz N, Farber L, Morsches B (1992) Psoriasis treatment with etretinate versus cyclosporin A. Clinical course and serum concentrations of soluble interleukin-2 receptors and CD8 antigen. Eur J Dermatol 2:224-230
22. Kemmett D, Symonds JA, Colver GB, Duff GW (1989) Serum IL-2 receptor levels in patients with psoriasis. Br J Dermatol 120:285-314
23. Wakita H, Takigawa M (1994) E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 130:457-463
24. Ohta Y, Katayama I, Funato T, Yokozeki H, Nishiyama S, Hirano T, Kishimoto T, Nishioka K (1991) In situ expression of messenger RNA of interleukine-6 involved in formation of psoriatic lesions. Arch Dermatol Res 283:351-356